Development of Rift Valley fever (RVF) vaccine by genetic joining of the RVF-glycoprotein Gn with the strong adjuvant subunit B of cholera toxin (CTB) and expression in bacterial system

One of the mosquito-borne zoonotic diseases is the Rift Valley fever virus (RVFV). Currently, there is no completely licensed vaccine that can be used to vaccinate animals or humans outside endemic areas. The aim of this work was to use the RVFV glycoprotein (Gn) and the subunit B of cholera toxin (...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Essam H., Taha, Ramadan, Ghramh, Hamed A., Kilany, Mona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864185/
https://www.ncbi.nlm.nih.gov/pubmed/31762643
http://dx.doi.org/10.1016/j.sjbs.2018.08.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864185/
https://www.ncbi.nlm.nih.gov/pubmed/31762643
http://dx.doi.org/10.1016/j.sjbs.2018.08.019

Ejemplares similares